First, we used anti-EpCAM-coated immunomagnetic beads and the IsoFlux® system (Fluxion Biosciences, Alameda, CA, USA), which displays great sensitivity in the identification of HCC-derived CTCs [64]. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.